cartouche ECN WORKSHOP
-

Abstracts

2023 - Poster

Mechanisms-Epidemiology

Which is the most appropriate sonographic definition for asymptomatic hyperuricemia with msu crystal deposits?

Peral-Garrido Ml, Gómez Sabater S, Caño Alameda R, Bermúdez García S, Lozano Palencia Mt Sánchez Ortiga R Perdiguero Gil M, Caro Martínez E, Ruiz García C, Francés R, Pascual E, Andrés M.

2023 - Poster

Therapeutics-Miscellaneous

Treatment of gout patients in seven primary care centers from barcelona

Cesar Diaz-Torne(1), Daniel Martinez-Laguna(2), Raquel Gayarre (3), Meritxell Aivar (4), Jordi Hoyo (5), Angeles Conesa (2), Carlen Reyes (6), Cristina Carbonell (7), Jose Luis Estebanez (8), Maria Antonia Pou (3)

2023 - Oral communication

Therapeutics-Miscellaneous

Factors associated to loss for follow-up in a prospective gout cohort

Fernando Perez-Ruiz, Cristina Vazquez-Puente, Maria Del Consuelo Modesto- Caballero, Ana María Herrero-Beites

2023 - Poster

Mechanisms-Epidemiology

Diagnosis of gout in electronic primary care medical records

Cesar Diaz-Torne(1), Daniel Martinez-Laguna(2), Jose Luis Estebanez(3), Angeles Conesa(2), Jordi Hoyo(4) , Cristina Carbonell(5), Meritxell Aivar(6), Carlen Reyes(7), Raquel Gayarre(8), Maria Antonia Pou(8)

2023 - Poster

Mechanisms of Calcification

TGF-Β enhances phosphate-driven mineralization of human oa articular chondrocytes

Roderick H.M., J Stassen, Guus G.H. Van Den Akker, Don A.M Surtel, Andy Cremers, Marjolein M.C. Caron, Lodewijk W. Van Rhijn, Tim J.M. Welting

2023 - Oral communication

Mechanisms of Calcification

Similar histological calcium crystal deposition in osteoarthritis and chondrocalcinosis

Sina Stücker, Franziska Kosslowski, Christoph H. Lohmann, Jessica Bertrand

2023 - Poster

OA-Genetics and EUROGOUT-Inflammation

Transcriptomic analysis of peripheral blood mononuclear cells in gout and hyperuricemia

Valentin Nica, Georgiana Cabău, Orsolya Gaal, Medeea Badii, Andreea-Manuela Mirea, Ioana Hotea, Hint Consortium, Cristina Pamfil, Simona Rednic, Radu A. Popp, Tania O. Crișan, Leo A.B. Joosten

2023 - Oral communication

Rare diseases

Altered transcription activity in gout reveals new genetic targets for msu crystal-dependent inflammation

Richard J Reynolds, Megan Leask, Nicholas Sumpter, Tony R Merriman, Pariyaphon Lertprachakwong, Jeffrey C Edberg.

2023 - Oral communication

Therapeutics-Miscellaneous

Real-life results of urate-driven pharmacotherapy with three urate lowering drugs in gout: allopurinol, febuxostat and benzbromarone

Hotea I 1,2, Giesen T1, Comarniceanu A 1, Efde M 1, Van Osch F 3, Janssen M 1, Jansen Tltha 1,4.

2023 - Oral communication

Mechanisms of Calcification

Effects of de novo calcification in a new ex-vivo human model of osteoarthritis

Elodie Faure , Julien Wegrzyn 2, Ilaria Bernabei 1, Nicolas Bertheaume 3, Tristan Pascart 3, Thomas Hugle 1, Nathalie Busso 1, Sonia Nasi 1

2023 - Oral communication

Therapeutics-Miscellaneous

Rationale and design for PODAGRA II: a multicenter randomized phase 2/3 study assessing the efficacy and safety of dapansutrile, an orally administered specific inhibitor of the nlrp3 inflammasome in subjects with an acute gout flare

Tim Jansen, Phil Piscitelli, Cynthia Barrow, Kip Vought, Amy Poshusta, Heather Kapushoc, Andrea Leonard-Segal, Mustafa Noor, Damaris Skouras, Charles Dinarello, Naomi Schlesinger

2023 - Poster

Mechanisms-Epidemiology

Antinuclear antibodies in gout: the new vomit (victims of modern immunology techniques)

Ana Maria Herrero-Beites, Cristina Vázquez-Puente, Maria Del Consuelo Modesto-Caballero, Fernando Pérez-Ruiz

2023 - Oral communication

Mechanisms of Calcification

Ex vivo reversion and inhibition of calcification using therapeutic nanoparticular formulations

Franziska Linss 1, Jacqueline Bodes 1, Dennis Mulac 1, Klaus Langer 1 Anja Feldmann 2, Yvonne Nitschke 2, Frank Rutsch 2

2023 - Oral communication

Mechanisms-Epidemiology

Hyperuricemia is associated with coronary artery atherosclerosis in men: results from the SCAPIS study

Panagiota Drivelegka1, Helena Forsblad-D’Elia 1, Göran Bergström 2,3, Erika Fagman 4,5, Lennart Th Jacobsson 1, Mats Dehlin 1

2023 - Poster

OA-Genetics and EUROGOUT-Inflammation

Interleukin 1 receptor type i and ii variation in patients with gout and hyperuricemic individuals

Orsolya I. Gaal1,2, Valentin Nica1, Medeea Badii1,2, Georgiana Cabău1, Ioana Hotea3, Hint Consortium, Cristina Pamfil3, Megan Leask4,5, Tony R. Merriman4,5, Tania O. Crișan1,2, Leo A.B. Joosten 1,2

2023 - Poster

Mechanisms-Epidemiology

Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment

Blanka Stibůrková 1,2, Kateřina Pavelcová1, Jana Mašínová1, Lenka Hasikova 1, Karel Pavelka 1, Aleš Kvasnička 3,4, David Friedecký 3,4, Radana Brumarová 3,4, Markéta Pavlíková 5